贝瑞基因
(000710)
| 流通市值：26.07亿 | | | 总市值：28.95亿 |
| 流通股本：3.18亿 | | | 总股本：3.54亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 230,307,503.75 | 290,203,899.18 | 246,677,815.54 | 338,151,330.53 |
| 结算备付金 | - | - | 0 | - |
| 拆出资金 | - | - | 0 | - |
| 衍生金融资产 | - | - | 0 | - |
| 应收票据及应收账款 | 1,064,985,647.45 | 886,615,825.8 | 897,716,798.46 | 815,208,041.91 |
| 其中：应收票据 | - | 3,876,480 | 9,126,720 | 7,257,600 |
| 应收账款 | 1,064,985,647.45 | 882,739,345.8 | 888,590,078.46 | 807,950,441.91 |
| 应收款项融资 | - | - | 0 | - |
| 预付款项 | 17,816,875.01 | 15,622,171.82 | 10,752,214.14 | 8,279,682.68 |
| 应收保费 | - | - | 0 | - |
| 应收分保账款 | - | - | 0 | - |
| 应收分保合同准备金 | - | - | 0 | - |
| 其他应收款合计 | 12,202,792.42 | 8,279,682.4 | 5,100,313.7 | 4,973,294.75 |
| 其中:应收利息 | - | 0 | - | 0 |
| 买入返售金融资产 | - | - | 0 | - |
| 存货 | 193,549,175.5 | 204,030,221.77 | 204,820,105.11 | 229,302,829.83 |
| 合同资产 | - | - | 0 | - |
| 一年内到期的非流动资产 | - | - | 0 | - |
| 其他流动资产 | 65,087,746.87 | 95,747,257.37 | 66,022,192.05 | 63,224,956.08 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,595,574,893.32 | 1,514,302,599.28 | 1,442,724,961.38 | 1,472,996,759.37 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | - | 0 | - |
| 债权投资 | - | - | 0 | - |
| 其他债权投资 | - | - | 0 | - |
| 长期应收款 | - | - | 0 | - |
| 长期股权投资 | 209,147,096.17 | 187,923,364.85 | 43,452,734.19 | 44,446,022.55 |
| 其他权益工具投资 | - | - | 0 | - |
| 其他非流动金融资产 | 3,958,454.47 | 4,025,903.09 | 4,007,939.39 | 4,000,991.17 |
| 投资性房地产 | - | - | 0 | - |
| 固定资产 | 401,149,477.65 | 651,930,598.77 | 659,768,917.71 | 676,808,155.99 |
| 在建工程 | - | 229,840,367.12 | 235,280,547.01 | 230,802,870.8 |
| 生产性生物资产 | - | - | 0 | - |
| 油气资产 | - | - | 0 | - |
| 使用权资产 | 7,163,223.92 | 9,782,524.12 | 13,557,897.44 | 15,805,517.12 |
| 无形资产 | 5,624,495.35 | 47,867,608.73 | 47,550,105.37 | 49,670,552.88 |
| 开发支出 | 58,044,321.58 | 50,854,454.99 | 45,632,395.04 | 40,859,369.12 |
| 商誉 | 13,433,638.57 | 13,433,638.57 | 13,433,638.57 | 13,433,638.57 |
| 长期待摊费用 | 61,885,071.19 | 9,221,384.37 | 10,210,332.04 | 7,578,846.5 |
| 递延所得税资产 | 153,293,064.22 | 153,327,516.05 | 153,530,512.4 | 151,268,961.51 |
| 其他非流动资产 | 30,107,692.48 | 30,107,692.48 | 30,107,692.48 | 33,493,461.76 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 943,806,535.6 | 1,388,315,053.14 | 1,256,532,711.64 | 1,268,168,387.97 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,539,381,428.92 | 2,902,617,652.42 | 2,699,257,673.02 | 2,741,165,147.34 |
| 流动负债: | | | | |
| 短期借款 | 106,996,255.68 | 147,065,868.31 | 164,774,145.97 | 202,637,334.67 |
| 向中央银行借款 | - | - | 0 | - |
| 吸收存款及同业存放 | - | - | 0 | - |
| 拆入资金 | - | - | 0 | - |
| 交易性金融负债 | - | - | 0 | - |
| 衍生金融负债 | - | - | 0 | - |
| 应付票据及应付账款 | 290,003,596.32 | 315,902,271.32 | 278,768,604.44 | 292,484,114.6 |
| 其中：应付票据 | 38,126,866.45 | 38,126,866.45 | 15,505,406.31 | 15,505,406.31 |
| 应付账款 | 251,876,729.87 | 277,775,404.87 | 263,263,198.13 | 276,978,708.29 |
| 预收款项 | - | 0 | 0 | 0 |
| 合同负债 | 114,605,346.96 | 403,583,300.58 | 127,814,231.18 | 110,753,277.08 |
| 卖出回购金融资产款 | - | - | 0 | - |
| 应付手续费及佣金 | - | - | 0 | - |
| 应付职工薪酬 | 40,142,471.73 | 40,490,057.13 | 42,160,628.59 | 51,230,318.68 |
| 应交税费 | 15,792,248.38 | 16,196,258.34 | 19,445,287.5 | 25,370,484.7 |
| 其他应付款合计 | 13,334,142.2 | 14,904,297.24 | 15,375,832.32 | 16,025,718.43 |
| 应付分保账款 | - | - | 0 | - |
| 保险合同准备金 | - | - | 0 | - |
| 代理买卖证券款 | - | - | 0 | - |
| 代理承销证券款 | - | - | 0 | - |
| 一年内到期的非流动负债 | 5,106,680.32 | 7,980,962.19 | 54,098,761.82 | 55,255,298.91 |
| 其他流动负债 | 5,781,461.69 | 9,147,260 | 10,593,116.53 | 9,335,255.42 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 591,762,203.28 | 955,270,275.11 | 713,030,608.35 | 763,091,802.49 |
| 非流动负债: | | | | |
| 长期借款 | - | 0 | 42,183,109.01 | 42,183,109.01 |
| 应付债券 | - | - | 0 | - |
| 优先股 | - | - | 0 | - |
| 永续债 | - | - | 0 | - |
| 租赁负债 | 2,363,658.81 | 2,514,529.53 | 2,433,650.78 | 3,503,280.14 |
| 长期应付款 | - | - | 0 | - |
| 预计负债 | - | - | 0 | - |
| 递延收益 | 10,872,000 | 10,872,000 | 10,822,000 | 11,019,500 |
| 递延所得税负债 | 26,318,074.1 | 26,382,001.85 | 26,716,652.92 | 26,766,231.72 |
| 其他非流动负债 | - | - | 0 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 39,553,732.91 | 39,768,531.38 | 82,155,412.71 | 83,472,120.87 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 631,315,936.19 | 995,038,806.49 | 795,186,021.06 | 846,563,923.36 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 353,521,465 | 353,521,465 | 353,521,465 | 353,521,465 |
| 其他权益工具 | - | - | 0 | - |
| 优先股 | - | - | 0 | - |
| 永续债 | - | - | 0 | - |
| 资本公积 | 1,156,192,042.36 | 1,156,192,042.36 | 1,156,192,042.36 | 1,156,192,042.36 |
| 减:库存股 | - | - | 0 | 0 |
| 其他综合收益 | 16,168,446 | 17,074,618 | 16,552,727.14 | 16,501,304.02 |
| 专项储备 | - | - | 0 | - |
| 盈余公积 | 80,849,357.82 | 80,849,357.82 | 80,849,357.82 | 80,849,357.82 |
| 一般风险准备 | - | - | 0 | - |
| 未分配利润 | 267,356,386.51 | 266,233,721.43 | 265,206,000.54 | 256,970,877.59 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,874,087,697.69 | 1,873,871,204.61 | 1,872,321,592.86 | 1,864,035,046.79 |
| 少数股东权益 | 33,977,795.04 | 33,707,641.32 | 31,750,059.1 | 30,566,177.19 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,908,065,492.73 | 1,907,578,845.93 | 1,904,071,651.96 | 1,894,601,223.98 |
| 负债和股东权益合计 | 2,539,381,428.92 | 2,902,617,652.42 | 2,699,257,673.02 | 2,741,165,147.34 |
| 公告日期 | 2024-10-29 | 2024-08-23 | 2024-04-25 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |